Flagship Pioneering

Flagship Pioneering is a life sciences venture capital and company creation firm based in Cambridge, Massachusetts. Founded in 1999/2000 by Noubar Afeyan and Ed Kania, the company focuses on inventing, funding, and incubating innovative biotechnology, health, and sustainability companies. Flagship employs a unique model that combines scientific creativity with systematic entrepreneurship, starting with bold “what-if” questions that challenge existing scientific paradigms. The firm has founded over 100 bioplatform companies, which are designed to generate multiple products addressing significant unmet needs in human health and environmental sustainability. Flagship operates through two main units: VentureLabs™, which invents and launches transformative companies, and Venture Capital, which finances early-stage ventures. With approximately $14 billion in assets under management, Flagship has created over $60 billion in aggregate value from its portfolio, which includes notable companies like Moderna, Foghorn Therapeutics, and Inari Agriculture. The team at Flagship comprises scientists, entrepreneurs, and capital managers dedicated to fostering innovation and collaboration in the life sciences sector.